SAN RAFAEL, Calif., April 22, 2024 (Globe Newswire) — Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) (the “Company”), an industry leader in medical and industrial exoskeleton technology, announced today that plans to announce its first quarter 2024 financial and operating results after the close of business on Monday, April 29, 2024. Management will hold a conference call beginning at 1:30 PM PT/4:30 PM ET to discuss financial results and recent developments. Business development.
A live webcast of the event is available on the Investors section of our website. www.eksobionics.com,or Please click here. Investors wishing to listen to the conference call should dial 877-407-3036 for domestic calls or 201-378-4919 for international calls.
A replay of the webcast will also be available on our website for one month after the call ends.
About Ekso Bionics®
Ekso Bionics® is a leading developer of exoskeleton solutions that expand human potential by supporting or enhancing muscle strength, endurance, and mobility across medical and industrial applications. Founded in 2005, the company continues to draw on its industry-leading expertise to design the most advanced and innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company known for offering a wide range of technologies, from helping people with paralysis get up and walk to improving human performance in the field around the world. . The company is headquartered in the San Francisco Bay Area and is traded on the Nasdaq Capital Market under the symbol “EKSO.” See below for more information. www.eksobionics.com Or follow @EksoBionics on X.
contact:
david carey
212-867-1768
investor@eksobionics.com
